MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-13-0001087
Hauz Pharma Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹30.46 Cr
▲ 14% YoY
Net profit · FY 2024
₹16.28 Lakh
Net margin 0.5%
EBITDA · FY 2024
₹1.66 Cr
EBITDA margin 5.5%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹12.15 Cr
Satisfied ₹11.43 Cr
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings
About Hauz Pharma Private Limited
Data last updated:
Hauz Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 May 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2009PTC031626. Its GSTIN is 03AACCH2190K1ZR (Punjab). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sanjay Kumar Sinha (Managing Director) and Vikas Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 290 First & Second Level Motor Market Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2024, the company reported a revenue of ₹30.46 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹16.28 Lakh (net margin 0.5%) and EBITDA of ₹1.66 Cr (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 11% over five years.
As per MCA filings, the company has open charges of ₹12.15 Cr and satisfied charges of ₹11.43 Cr on record. Court records list 15 cases involving the company, including 6 filed by the company and 9 filed against it; 3 cases are pending.
Hauz Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0001087). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hauzpharma.in.
Company details
CIN U24232CH2009PTC031626
Registration Number 031626
Incorporation Date 29 May 2009
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-13-0001087
Recognitions & Rankings of Hauz Pharma
Contact details
Hauz Pharma Private Limited's registered office is in Chandigarh, Chandigarh. Its website is hauzpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressScf 290 First & Second Level Motor Market Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hauz Pharma Private Limited, buy the company report.
Comprehensive company report
Hauz Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Hauz Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hauz Pharma Private Limited, buy the company report.
Financials of Hauz Pharma Private Limited
FY 2025 filings availableHauz Pharma Private Limited reported revenue of ₹30.46 Cr (up 14% YoY) for FY 2024.
Revenue · FY 2024
₹30.46 Cr ▲ 14%
Net profit · FY 2024
₹16.28 Lakh margin 0.5%
EBITDA · FY 2024
₹1.66 Cr margin 5.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 9%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 28%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 14% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.66 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.28 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hauz Pharma Private Limited, buy the company report.
Board of directors of Hauz Pharma Private Limited
Hauz Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kumar Sinha Also directs: Sanovia Biotech Private Limited | Managing Director | 29 May 2009 | 17 Years 5 Months | Current |
| Vikas Sharma Also directs: Rouzel Pharma Private Limited, Sanovia Biotech Private Limited | Director | 01 Jun 2009 | 17 Years 4 Months | Current |
Peer comparison
Hauz Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Delvin Formulations Private Limited | ₹30.87 Cr (FY 2023) | 26.0% | Kanchipuram, Tamil Nadu, India | |||
| Algen Healthcare Limited | ₹30.69 Cr (FY 2025) | 5.0% | Delhi, India | |||
| Glendale Biomed Private Limited | ₹30.54 Cr (FY 2023) | 51.0% | Mumbai, Maharashtra, India | |||
| Hauz Pharma Private Limitedthis company | ₹30.46 Cr (FY 2024) | ₹16.28 Lakh | 0.5% | 14.0% | Chandigarh, India | |
| Libraw Pharma Excipients Private Limited | ₹30.37 Cr (FY 2025) | 12.0% | New Delhi, Delhi, India | |||
| Psa Chemicals and Pharmaceuticals Pvt Ltd | ₹30.31 Cr (FY 2025) | 4.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Hauz Pharma Private Limited, buy the company report.
Auditor
Hauz Pharma Private Limited is audited by Sushil K. Singla & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sushil K. Singla & CO | FY 2022 | 001023N |
Shareholding
The shareholding of Hauz Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hauz Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12.15 Cr
Satisfied charges
₹11.43 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2025 | 101182989 | Canara Bank | ₹28.9 Lakh | Open | |
| 19 Sep 2025 | 101182973 | Canara Bank | ₹24.5 Lakh | Open | |
| 21 Dec 2024 | 101039842 | Canara Bank | ₹11.25 Lakh | Open | |
| 22 Oct 2024 | 101017597 | Canara Bank | ₹10 Lakh | Open | |
| 02 Jul 2024 | 100976066 | Canara Bank | ₹11.4 Cr | Open |
To see the full charge records of Hauz Pharma Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Hauz Pharma Private Limited has 15 court cases on record: 6 filed by Hauz Pharma, 9 filed against it. 3 cases are pending and 12 are disposed.
Total cases
15
Filed by the company
6
Filed against the company
9
Pending
3
Disposed
12
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 3 | 0 |
| High courts | 6 | 6 | 3 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (CRR) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| District court, Yamunanagar, Haryana | Civil suit | Filed against the company by Biochemix Healthcare Pvt Ltd Through Director Pankaj Kumar | Disposed |
| High Court, MAHARASHTRA | Court case (LPETN) | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
To see the full case history of Hauz Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Hauz Pharma Private Limited was last rated by Crisil on 19 May 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 19 May 2019 |
To see the full credit ratings and regulatory alerts of Hauz Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hauz Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hauz Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AACCH2190K1ZR | Punjab | Active | 17 Jul 2022 |
To see the full GST registrations and return filing status of Hauz Pharma Private Limited, buy the company report.
Recent activity
Hauz Pharma Private Limited has 6 board changes on record since 2009: 2 appointments and 4 cessations. The latest: Deepika Sharma ceased to be Director on 29 Jun 2019.
AGM
Hauz Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Canara Bank amounted to Rs. 28.90 Lakh with Charge ID 101182989 was registered on 30 Sep 2025.
Charges
A charge with Canara Bank amounted to Rs. 24.50 Lakh with Charge ID 101182973 was registered on 19 Sep 2025.
Charges
A charge with Canara Bank of Rs. 1,140.00 Lakh registered on 02 Jul 2024 with Charge ID 100976066 was modified on 15 May 2025.
Charges
A charge registered on 07 Mar 2017 via Charge ID 100094787 with Others was fully satisfied on 25 Apr 2025.
Filing
Hauz Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge registered on 06 Jul 2023 via Charge ID 100780165 with Hdfc Bank Limited was fully satisfied on 30 Mar 2025.
Charges
A charge with Canara Bank amounted to Rs. 11.25 Lakh with Charge ID 101039842 was registered on 21 Dec 2024.
Charges
A charge with Canara Bank amounted to Rs. 10.00 Lakh with Charge ID 101017597 was registered on 22 Oct 2024.
Charges
A charge registered on 25 Jul 2023 via Charge ID 100763889 with Others was fully satisfied on 31 Jul 2024.
Charges
A charge registered on 14 Jul 2022 via Charge ID 100598127 with Others was fully satisfied on 31 Jul 2024.
Charges
A charge with Canara Bank amounted to Rs. 1,140.00 Lakh with Charge ID 100976066 was registered on 02 Jul 2024.
12 earlier events are in the company report.
Frequently asked questions
Hauz Pharma is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 May 2009 (17+ years old) and is registered under CIN U24232CH2009PTC031626.
Hauz Pharma has 2 current directors:
- Sanjay Kumar Sinha - Managing Director
- Vikas Sharma - Director
The latest financial statements of Hauz Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hauz Pharma is 03AACCH2190K1ZR, registered in Punjab. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Hauz Pharma is U24232CH2009PTC031626. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hauz Pharma has 15 court cases on record: 6 filed by the company and 9 filed against it. 3 are pending. Most are in the district courts.
Hauz Pharma was incorporated on 29 May 2009, making it 17+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Hauz Pharma by revenue are Delvin Formulations Private Limited, Algen Healthcare Limited, Glendale Biomed Private Limited, Libraw Pharma Excipients Private Limited, Psa Chemicals and Pharmaceuticals Pvt Ltd, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Deepika Sharma ceased to be Director on 29 Jun 2019. Jagjit Singh ceased to be Director on 31 Dec 2014. Sanjay Kumar Sinha ceased to be Director on 25 Feb 2011. Hauz Pharma has 6 board changes on record in total.
Yes, Hauz Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-HR-13-0001087).
Hauz Pharma can be reached through the website hauzpharma.in. Its registered office is in Chandigarh, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages